Characterizing Fluid Response and Sepsis Progression in Emergency Department Patients.


Journal

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference
ISSN: 2694-0604
Titre abrégé: Annu Int Conf IEEE Eng Med Biol Soc
Pays: United States
ID NLM: 101763872

Informations de publication

Date de publication:
Jul 2019
Historique:
entrez: 18 1 2020
pubmed: 18 1 2020
medline: 26 2 2020
Statut: ppublish

Résumé

Sepsis and septic shock are major global public health concerns. The main therapies for sepsis-related hypotension are fluid resuscitation and vasopressor therapy, though it can be challenging to determine the amount of fluid that should be given or the optimal timing to transition to vasopressor administration. To characterize patients' response to fluid bolus therapy (FBT) and analyze the sepsis progress using multiple vital signs, we mined a database containing 761 patients presenting to the Emergency Department (ED) with vital signs and laboratory values indicating high risk of septic shock. By clustering the patients' mean arterial pressure (MAP) time series during a time window around FBT, we found that clusters showing fluid responsiveness during the two hours after FBT only included about 25% of studied boluses. In addition, MAP responses tended to vary based on the initial MAP level. We also found that the trajectories of heart rate and MAP in a 2-D plane demonstrated general trends related to the hemodynamic progression of sepsis and previously described phases of septic shock. Potentially compensatory and decompensatory responses of the cardiovascular system to the insults of sepsis were reflected in the clusters representative of different phases.

Identifiants

pubmed: 31945949
doi: 10.1109/EMBC.2019.8856521
doi:

Substances chimiques

Vasoconstrictor Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

510-513

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH